-
Product Insights
NewJOTEC GmbH Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our JOTEC GmbH Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Jotec GmbH (Jotec), a subsidiary of CryoLife Inc, is a medical device company that develops, produces and markets implants for the treatment of aortic and peripheral vascular disease. Its product portfolio includes thoracic stent grafts, abdominal stent grafts, peripheral stent-grafts, stents, e-xtra design engineering, surgical device and accessories. It also provides conventional grafts and interventional implants for cardiovascular surgery, radiology...
-
Product Insights
NewFina Biotech SL Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Fina Biotech SL Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Fina Biotech SL (Fina), formerly Indas Biotech is a biotechnology projects developer. It discovers new diagnostic and therapeutic techniques for the healthcare sector. The company finances, selects, develops, and markets biotechnology projects. It offers halosperm that is a kit to determine the degree of DNA fragmentation in human sperm. Fina also provides services to new tools for monitoring, diagnosis,...
-
Product Insights
NewBoston Scientific Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Boston Scientific Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Boston Scientific Corp (Boston Scientific) is a medical technology company that is involved in the development, manufacturing and commercialization of devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology and vascular surgery....
-
Product Insights
NewShenzhen Salubris Pharmaceuticals Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Shenzhen Salubris Pharmaceuticals Co Ltd (Salubris) focuses on research, development, manufacture and distribution of pharmaceutical products. The company produces and markets medicines to treat diabetes; partial onset seizures; cardiovascular and cerebrovascular indications. It also offers anti-tumor; and anti-infective drugs targeting septicemia, meningitis, respiratory, skin and soft tissue, genital and reproductive system infections. Salubris is investigating small molecules...
-
Product Insights
NewDaidalos Solutions BV Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Daidalos Solutions BV Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Daidalos Solutions BV (Daidalos Solutions) is a medical device company. The company offers products such as sutureless biological heart valve prostheses, sutureless mechanical heart valve prostheses, sutureless heart valve repair rings, sutureless working channels and ports, sutureless closing devices, and sutureless vascular connectors. It provides applicators for sutureless heart valve prostheses and repair rings, loading devices for sutureless heart...
-
Product Insights
NewCell>Point LLC Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Cell>Point LLC Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Cell>Point LLC (Cell>Point) is a bio pharmaceutical company that offers therapeutic compounds. The company develops and markets intra-nuclear molecular imaging and therapeutic compounds. It provides ethylenedicysteine drug conjugate technology, cancer imaging, cardiology imaging, intra-nuclear therapy, beta cell imaging, radio and chemotherapy delivery system, n4-technology, and dual agent technology. Cell>Point provides n4-(tetraaza cyclopentadiene) technology to image and treat certain neurological diseases...
-
Product Insights
NewShanghai MicroPort Medical Group Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Shanghai MicroPort Medical Group Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Shanghai MicroPort Medical Group Co Ltd (MicroPort), formerly MicroPort Medical (Shanghai) Co Ltd, a subsidiary of Otsuka Holdings Co Ltd, is a medical device company that offers medical solutions in various therapeutic fields. The company’s products categories include cardiovascular, orthopedic, endovascular, electrophysiological, neurovascular, diabetes care and endocrinal, surgical, and accessories. Its cardiology products include drug-eluting coronary...
-
Product Insights
NewAngioDynamics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our AngioDynamics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. Its products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis...
-
Sector Analysis
Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Coronary Stents Market Overview The coronary stents market size was valued at $4.37 billion in 2023. The market will grow at a CAGR of less than 1% during 2023-2033. Factors such as rapidly changing lifestyles and growing unhealthy diets are leading to increased risk of coronary heart disease, which will drive the market growth in coming years. A coronary stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a...
-
Product Insights
Standard Balloon Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Standard Balloon Catheters Pipeline Market Report Overview Standard balloon catheters are used to open the arteries blocked by plaque build-up. These catheters compress plaque and dilate the arterial wall to restore normal blood flow through the vessel. A standard balloon catheter has a small, folded balloon at the end of the catheter. The Standard Balloon Catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report...